MAGNESIUM Calmagite
- UID
- IMP/IVD/2023/000051_f5aae3b1b43f1f7cb181595572e131bb_38cd639e83da6271b744a49393bcc95b
- Device class
- Class B
- Brand name
- BIOLABO ACID CALCIUM Arsenazo III Method
- License holder
- Wheecon Instruments Private Limited
- Approving authority
- CDSCO
- Product information
- Adult human body (BIOLABO ACID CALCIUM Arsenazo III Method) contains 21 to 28 g of magnesium. Of this, about 60% is in bone, 20% in skeletal muscle, 19% in other cells, and about 1% in the extracellular fluids. About 30% of magnesium in plasma is associated with proteins (BIOLABO ACID CALCIUM Arsenazo III Method). Consequently, a change in the concentration in albumin can affect the concentration in magnesium. Hypomagnesaemia may be a secondary effect in hypocalcemic or calcium-deficient tetany. Conditions that have been associated with hypomagnesemia include chronic alcoholism, childhood malnutrition, lactation, malabsorption, acute pancreatitis, hypothyroïdism, chronic glomerulonephritis, aldosteronism, digitalis intoxication and prolonged intravenous feeding. Hypermagnesaemia have been observed in dehydratation, severe diabetic acidosis, and immediately following myocardial infarction
MAGNESIUM Calmagite is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000051_f5aae3b1b43f1f7cb181595572e131bb_38cd639e83da6271b744a49393bcc95b. This device is marketed under the brand name BIOLABO ACID CALCIUM Arsenazo III Method. The license holder is Wheecon Instruments Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.